000 06295nam a22006495i 4500
001 978-1-0716-2605-4
003 DE-He213
005 20260610083713.0
007 cr nn 008mamaa
008 221012s2023 xxu| s |||| 0|eng d
020 _a9781071626054
_9978-1-0716-2605-4
024 7 _a10.1007/978-1-0716-2605-4
_2doi
050 4 _aRA1190-1270
072 7 _aMMGT
_2bicssc
072 7 _aMED106000
_2bisacsh
072 7 _aMKGT
_2thema
082 0 4 _a615.90072
_223
245 1 0 _aMethods for Novel Psychoactive Substance Analysis
_h[electronic resource] /
_cedited by Marta Concheiro, Karl B. Scheidweiler.
250 _a1st ed. 2023.
264 1 _aNew York, NY :
_bSpringer US :
_bImprint: Humana,
_c2023.
300 _aX, 280 p. 27 illus., 10 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
341 0 _bTable of contents navigation
_2onix
341 0 _bSingle logical reading order
_2onix
341 0 _bShort alternative textual descriptions
_2onix
341 0 _bUse of color is not sole means of conveying information
_2onix
341 0 _bUse of high contrast between text and background color
_2onix
341 0 _bNext / Previous structural navigation
_2onix
341 0 _bAll non-decorative content supports reading without sight
_2onix
347 _atext file
_bPDF
_2rda
490 1 _aMethods in Pharmacology and Toxicology,
_x1940-6053
505 0 _aIntroduction/Overview -- Target analysis of synthetic cannabinoids in blood and urine -- Target analysis of synthetic cathinones in blood and urine -- Target analysis of phenethylamines, piperazines and tryptamines in blood and urine -- Target analysis of synthetic opioids in blood and urine -- Target analysis of synthetic benzodiazepines in blood and urine -- Target analysis of NPS in alternative matrix hair -- Target analysis of NPS in alternative matrix oral fluid -- Target analysis of NPS in other alternative matrices (dried blood spots, meconium) -- Target analysis of NPS in postmortem samples -- High Resolution Mass Spectrometry in NPS qualitative analysis -- High Resolution Mass Spectrometry in NPS quantitative analysis -- High Resolution Mass Spectrometry in identification of new analytes & metabolites -- Alternative NPS screening approaches for high-throughput laboratories.
520 _aThis collection provides detailed information on current advances in analytical methods and strategies employed for monitoring and discovering a wide range of novel psychoactive substances (NPS) in clinical and forensic laboratories. The main classes of NPS in terms of prevalence include synthetic cannabinoids, synthetic cathinones, synthetic opioids, and designer or synthetic benzodiazepines, and this book explores selecting the appropriate sample matrix and analytical testing approaches for laboratories faced with NPS drug testing, such as in blood, urine, saliva, and hair. Written for the Methods in Pharmacology and Toxicology series, chapters in this volume feature the kind of detailed implementation advice from the experts that leads to successful results in the lab. Authoritative and practical, Methods for Novel Psychoactive Substance Analysis serves as an ideal guide for forensic and clinical toxicologists, pharmacologists and chemists inacademic and research settings, as well as for private laboratories seeking to increase our ability to test for these substances. @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536869121 1107305727 33554432 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1073732485 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; mso-bidi-font-size:11.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-US; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; mso-bidi-font-size:11.0pt; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-US; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}.
532 8 _aAccessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com.
532 8 _aNo reading system accessibility options actively disabled
532 8 _aPublisher contact for further accessibility information: accessibilitysupport@springernature.com
650 0 _aToxicology.
650 0 _aPharmaceutical chemistry.
650 0 _aDrug abuse.
650 0 _aCriminology.
650 1 4 _aToxicology.
650 2 4 _aPharmaceutics.
650 2 4 _aDrugs.
700 1 _aConcheiro, Marta.
_eeditor.
_0(orcid)0000-0002-3858-1280
_1https://orcid.org/0000-0002-3858-1280
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aScheidweiler, Karl B.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9781071626047
776 0 8 _iPrinted edition:
_z9781071626061
776 0 8 _iPrinted edition:
_z9781071626078
830 0 _aMethods in Pharmacology and Toxicology,
_x1940-6053
856 4 0 _uhttps://doi.org/10.1007/978-1-0716-2605-4
912 _aZDB-2-PRO
999 _c8020
_d8020